回归断点分析用于药物警戒:他汀类示例反映试验结果,显示危害证据很少
本研究利用临床实践研究数据链的前瞻性队列,纳入2010至2013年QRISK评分10至30、末次随访至2016年10月的患者,比较QRISK≥20与<20者,探索回归断点分析(RDA)评估他汀处方对总胆固醇及不良结局的影响。RDA证实他汀降低总胆固醇(均差-1.33 mmol/L,95%CI -1.93至-0.73),对糖尿病、肌痛和肌炎、肝病、CVD或死亡的不良效应证据很少,与RCT结果相似。结论提示RDA可用于按阈值处方的药物效应证据生成,但置信区间较宽,部分因对处方阈值依从性低。
要点
- RDA证实他汀处方降低总胆固醇,均差-1.33 mmol/L(95%CI -1.93至-0.73)。
- RDA对糖尿病、肌痛和肌炎、肝病、CVD或死亡的不良效应证据很少。
- RDA结果与RCT相似,非RDA分析与已发表观察性研究一致。
核心结论
- RDA可用于大型常规临床数据集,为按阈值处方的药物效应提供证据。
- 可检验的RDA假设得到满足,但置信区间较宽,部分因对处方阈值依从性低。
研究设计与样本
- 前瞻性队列研究,使用临床实践研究数据链,纳入2010至2013年QRISK评分10至30、末次随访至2016年10月的患者。
- 比较QRISK≥20与QRISK<20患者,探索RDA假设,进行概念验证分析(总胆固醇为结局),并研究他汀处方对不良结局的影响。
主要发现
- RDA证实他汀处方降低总胆固醇,均差-1.33 mmol/L(95%CI -1.93至-0.73)。
- RDA对糖尿病、肌痛和肌炎、肝病、CVD或死亡的不良效应证据很少。
- RDA分析结果与RCT结果相似;非RDA分析结果与已发表观察性研究一致。
临床怎么用
- 在按阈值处方的药物警戒中,可考虑使用RDA利用常规临床数据集评估药物效应。
- 解读RDA结果时需注意置信区间较宽及对处方阈值依从性低的影响。
局限性
- 置信区间较宽,部分由于对处方阈值依从性低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The study aims to explore the use of regression discontinuity analysis (RDA) to examine effects of prescription of statins on total cholesterol and adverse outcomes (type 2 diabetes, rhabdomyolysis and myopathy, myalgia and myositis, liver disease, CVD, and mortality). STUDY DESIGN AND SETTING: We conducted a prospective cohort study using the Clinical Practice Research Datalink including patients with QRISK scores of 10 to 30 in 2010 to 2013 who were last followed-up in October 2016. Comparing patients with QRISK≥20 and QRISK<20, we explored RDA assumptions, provided proof of concept analyses (total cholesterol as outcome), and investigated the effect of statins prescription on adverse outcomes. RESULT: RDA confirmed statin prescription reduced total cholesterol (Mean difference (MD) -1.33 mmol/L, 95%Confidence Interval (CI) -1.93 to -0.73). RDA provided little evidence for adverse effects on diabetes, myalgia and myositis, liver disease, CVD, or mortality. The RDA analysis findings are similar to RCT results. Findings from non-RDA analysis agree with published observational studies. CONCLUSION: RDA can be used with large routine clinical datasets to provide evidence on effects of medications which are prescribed according to a threshold. Testable RDA assumptions were satisfied, but confidence intervals were wide, partly due to the low compliance with the prescribing threshold.
引用
- Scott L, Redaniel MT, Booker M, et al. Regression discontinuity analysis for pharmacovigilance: statin example reflected trial findings showing little evidence of harm. J Clin Epidemiol. 2021. PMID: 34648942. doi:10.1016/j.jclinepi.2021.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。